Follicular Lymphoma
📧 Sign up to get email alerts when something new happens for Follicular Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms [Phase 1]
A Phase 1 trial evaluating the combination of bortezomib and flavopiridol in patients with recurrent or refractory indolent B-cell neoplasms…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating rituximab in combination with bevacizumab in patients with follicular lymphoma; results have been posted a…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL) [Phase 3]
Phase 3 trial evaluating Rituximab (MabThera) in elderly patients with untreated follicular lymphoma has completed. Results from the study h…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Phase II Cancer Vaccine Trial for Patients With Follicular Lymphoma [Phase 2]
A Phase II cancer vaccine trial for Follicular Lymphoma has completed enrollment with the study status marked as completed.
-
CLINICAL_TRIALS trial_result · 2014-10-06Clinical Trial Update: Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
This ClinicalTrials.gov update reports a terminated phase 1/2 trial evaluating fenretinide with rituximab for B-cell non-Hodgkin lymphomas; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas [Phase 2]
Phase 2 trial assessing idelalisib for indolent B-cell non-Hodgkin lymphomas completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating agatolimod sodium in combination with rituximab and Yttrium-90 ibritumomab tiuxetan for adults with re…
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial of vorinostat combined with decitabine in adults with advanced solid tumors or relapsed/refractory hematologic cancers, includ…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial update evaluating the combination of iodine-131 tositumomab with fludarabine phosphate in older patients undergoing autologous…
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Ofatumumab and Bortezomib in Subjects With Relapsed CD20+Diffuse Large B Cell, Follicular, or Mantle Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of ofatumumab and bortezomib in adults with relapsed CD20-positive lymphomas, including diffuse lar…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: Imexon for Relapsed Follicular and Aggressive Lymphomas [Phase 2]
Phase 2 clinical trial results for imexon in relapsed follicular lymphoma and various aggressive B-cell lymphomas have been completed with r…
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma [Phase 3]
Phase 3 trial evaluating rituximab alone and in combination with Roferon-A (interferon alfa) in follicular and other CD20+ indolent lymphoma…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating Velcade (bortezomib) in combination with rituximab for relapsed/refractory mantle cell lymphoma and follicular no…
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating immunochemotherapy with Zevalin (ibritumomab tiuxetan) and bone marrow transplant for follicular lymphoma has compl…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: S8947-9800-9911-0016A Vitamin D Insufficiency in Determining Prognosis in Patients With Newly Diagnosed Follicular Lymphoma
A completed SWOG trial evaluated whether Vitamin D insufficiency affects prognosis in patients with newly diagnosed Follicular lymphoma.
-
CLINICAL_TRIALS trial_result · 2014-04-29Clinical Trial Update: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia [Phase 1]
Phase 1 study of MK-2206 in pediatric patients with recurrent or refractory solid tumors or leukemias has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma [Phase 2]
This update reports on a Phase 2 trial of bortezomib with standard chemotherapy for relapsed or refractory follicular lymphoma, which was te…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: Bortezomib in Treating Patients With Lymphoproliferative Disorders [Phase 2]
Phase 2 study of bortezomib in recurrent lymphoproliferative disorders, including follicular lymphoma and mantle cell lymphoma; results were…
-
CLINICAL_TRIALS trial_result · 2014-04-01Clinical Trial Update: An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular Lymphoma [Phase 2]
Phase 2 trial evaluating the combination of bortezomib and rituximab for relapsed or refractory follicular lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2014-03-20Clinical Trial Update: A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating SGN-40 in combination with Rituximab in CD20-positive follicular and marginal zone B-cell non-Hodgkin's lymphoma ha…
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 2]
This update reports results from a Phase 2 trial of ixabepilone in relapsed or refractory aggressive non-Hodgkin lymphoma across multiple su…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating the combination of tanespimycin and bortezomib in adults with advanced solid tumors or lymphomas; the study was ter…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating CCI-779 (temsirolimus) in patients with recurrent or refractory B-cell non-Hodgkin lymphoma or chronic l…
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Autologous Vaccine for Follicular Lymphoma [Phase 1]
This clinical trial update notes the completion of a Phase 1 study of an autologous vaccine for follicular lymphoma sponsored by Icon Geneti…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of a geldanamycin analogue in patients with advanced solid tumors or Non-Hodgkin lymphoma has been terminated.